(2021) revealed that low STING expression in HCC patients significantly correlates with larger tumor volumes, elevated serum alpha-fetoprotein (AFP) levels, and reduced infiltration of CD8+ T cells. This evidence concerns the gene STING1 and hepatocellular carcinoma.